The Solabia Group is changing hands! Private equity firm Astorg succeeds TA Associates and becomes the majority shareholder. However, TA will reinvest in the business and will partner with Astorg to support Solabia in executing its growth plan.
Founded in 1972, Solabia leverages advanced biotechnology capabilities – including fermentation, enzymatic synthesis, plant extraction, and green chemistry – to develop “high-performance ingredients.”
Headquartered in Paris, Solabia operates 11 manufacturing sites and 8 R&D labs worldwide and employs over 900 staff. The company, which posted double-digit growth in the past five years, will focus on further accelerating international expansion – particularly in the US and Asia – and advancing its innovation roadmap.
The transaction is subject to customary regulatory approvals and is expected to close in the coming months. Financial terms were not disclosed. However, according to information from Capital Finance, the amount of the transaction would be between 1.1 and 1.2 billion euros, or almost 20 times the EBITDA, which is close to 60 million euros.